NYC FinTech.connect

NYC FinTech.connect

This is your chance to mingle with top FinTech professionals at Withum! Join us for a day filled with networking, panel discussions, and insights into the latest trends in the industry. Whether you're a seasoned pro or just starting out, this event is perfect for anyone looking to connect with like-minded individuals in the FinTech world. Don't miss out on this opportunity to learn, grow, and connect with the best in the business!

5:30 - 6:15pm Cocktail and networking reception
6:15 - 6:30pm Introductions, Alex Dundara, Partner, Withum
6:30 - 6:45pm Investor Introductions, David Hemenway, Founder, Angel Nest
Investor Panel:

-TBA
--TBA
--TBA

--TBA
6:45 - 8pm Guest Presenters
- Josh Gottesman , CEO, Embie Clinic
- Thiv Paramsothy, Founder & CEO, Hera Fertility
- Gitte Pederson, Co-Founder & CEO, Genoession
- Christine Rohan, CEO, Vasowatch
8:00 - 8:30pm Networking

Embie Clinic

Embie is enabling 10X more IVF via remote fertility care.
There are only 500 fertility clinics in the entire US but 50,000 OBGYNs. Embie turns any OBGYN office into a satellite fertility clinic, breaking down geographic barriers and drastically improving access to care - while radically improving patient experience.
At a time when everybody is talking about access to IVF, what is not being talked about is the fundamental shortage of the amount of available treatment. And, the deep geographic barriers that effectively make most of the US fertility deserts. Embie's enablement of remote treatment allows for an order of magnitude more IVF independent of geography.
Embie is live with our first two paying US fertility network customers! www.embieclinic.com

Hera FertilityAt Hera Fertility we help men become fathers by treating their infertility comfortably at home instead of in an awkward clinic. Our at-home test and app-based treatment program improve infertility over half the time. https://www.herafertility.co

Genomic ExpressionGenomic Expression is revolutionizing cancer treatment by analyzing tumor RNA and identifying the most effective therapies for patients.
Our OneRNA® platform is fully validated in breast and ovarian cancer and ready to scale. Supported by industry veterans with $1.7M in seed financing, and $6.5M in grants and $4.5M in lifetime revenue. www.genomicexpression.com

VasowatchVasowatch is an innovative healthcare technology company focused on enhancing maternal health outcomes by providing a non-invasive solution for assessing the risk of postpartum hemorrhage (PPH), a leading cause of maternal mortality. Founded in 2021 and based in Philadelphia, Vasowatch utilizes a wearable device that continuously monitors physiological data during labor and delivery, employing advanced algorithms to predict PPH risk accurately and in real-time. This technology enables healthcare teams to respond promptly to changes in a mother's condition, thereby improving obstetric outcomes and potentially saving lives. By integrating decision support tools into clinical practice, Vasowatch aims to transform maternal care and address health disparities in postpartum management. www.vasowatch.com

Host or Publisher Saddlerock Advisors